Bloomberg Law
Aug. 25, 2021, 9:40 PM

Moderna Seeks Full U.S. Approval for Its Covid-19 Vaccine (2)

Timothy Annett
Timothy Annett
Bloomberg News

Moderna Inc. said it had completed the application process for full approval of its Covid-19 vaccine in the U.S., putting the company on course to obtain the second such clearance from federal regulators.

The company said in a statement on Wednesday that it had finished the rolling submission process for an approval from the Food and Drug Administration. Moderna first launched the process in June with the beginnings of a so-called Biologics License Application. Since then, the company has been supplying data to regulators on its shot’s safety and effectiveness as it became available in clinical testing.

Moderna’s two-shot ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.